Research programme: autologous stem cell therapies - GWOXIAlternative Names: Autologous adipose-derived stem cells - GWOXI; GXNPC1; hADSC - GWOXI; human adipose-derived stem cells - GWOXI
Latest Information Update: 04 Jul 2016
At a glance
- Originator GWOXI Stem Cell Applied Technology
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Stroke
Most Recent Events
- 22 Jun 2016 GWOXI Stem Cell Applied Technology plans a phase I trial in Stroke in Taiwan (NCT02813512)